Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Cellebrite DI (NASDAQ:CLBT) Stock Gets Price Target Bump From Needham & Company LLC

Summary by MarketBeat
Needham & Company LLC upped their target price on Cellebrite DI from $12.50 to $14.00 and gave the stock a "buy" rating in a report on Thursday.

4 Articles

Morgan County CitizenMorgan County Citizen
+2 Reposted by 2 other sources
Center

Cellebrite DI Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Cellebrite DI (CLBT)

Cellebrite DI reported third-quarter results above key estimates on November 12, 2026, yet its shares traded down about 14% after the same report trimmed full-year revenue guidance again. Investors who lost money in the reversal may have legal rights.

·Madison, United States
Read Full Article
MarketBeatMarketBeat
Center

Cellebrite DI (NASDAQ:CLBT) Stock Gets Price Target Bump from Needham & Company LLC

Needham & Company LLC upped their target price on Cellebrite DI from $12.50 to $14.00 and gave the stock a "buy" rating in a report on Thursday.

·Sioux Falls, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 75% of the sources are Center
75% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

MarketBeat broke the news in Sioux Falls, United States on Friday, November 13, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Stock Markets icon

Stock Markets

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal